Thursday, December 22, 2022

MissionIRNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Deploys ASR and Emergency Communication Services for Five New Contracts

 Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots, has announced continued market expansion through securing five new contracts for its Autonomous Security Robot (“ASR”) and Blue Light Emergency Communication services across multiple U.S. states. The contracts and deployment locations include a property management group in Chicago, a police department in North Carolina, another tribal casino client in Oklahoma, an airport in New Jersey, as well as a construction company in Texas.

The announcement reads, “Knightscope’s expanded product line is helping its clients protect the places people live, work, study and visit in many new ways. In addition to this ongoing new growth, Knightscope perseveres with sustained renewals received from existing clients, further validating the long-term effectiveness of its technologies.”

To view the full press release, visit https://ibn.fm/spXyn

About Knightscope, Inc.

Knightscope is an advanced security technology company based in Silicon Valley that builds fully autonomous security robots that deter, detect and report. Knightscope’s long-term ambition is to make the United States of America the safest country in the world. For more information, visit the company’s website at www.knightscope.com.

NOTE TO INVESTORS: The latest news and updates relating to Knightscope are available in the company’s newsroom at https://ibn.fm/KSCP

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH-CBD (TM) Achieves Superior CBD Blood Absorption Levels in Hypertension Study

 Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that it has demonstrated superior cannabidiol (“CBD”) blood absorption levels from its patented DehydraTECH-CBD(TM) relative to those of published, pharmaceutical-grade CBD industry comparators. The results were obtained from the company’s recently completed, multi-week human clinical hypertension study – HYPER-H21-4. “DehydraTECH-CBD has repeatedly shown that it can be administered at much lower dose levels than other CBD formulations to achieve effective levels within the blood stream, as supported by this pharmaceutical-industry peer comparison,” said Chris Bunka, CEO of Lexaria Bioscience Corp. “This is extremely important to patients hoping to achieve positive health outcomes while using lower levels of medication with no serious side effects and also important to Lexaria as we pursue FDA registration of DehydraTECH-CBD.”

To view the full press release, visit https://ibn.fm/TvQy4

About Lexaria Bioscience Corp.

Lexaria’s patented drug delivery technology, DehydraTECH(TM), improves the way active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery. Since 2016, DehydraTECH has repeatedly demonstrated the ability to increase bio-absorption with cannabinoids, antiviral drugs, PDE5 inhibitors and more. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 27 patents granted and roughly 50 patents pending worldwide. For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://ibn.fm/LEXX

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html


MissionIRNewsBreaks – Vision Energy Corp. (VENG) Issues Development Update on Green Energy Hub

 Vision Energy (OTCQB: VENG) today provided a project development update on the company’s Green Energy Hub in the North Sea Port of Vlissingen, the Netherlands. According to the update, Vision Energy, through its wholly owned subsidiary Evolution Terminals BV, is concluding remaining requisite studies to support filing permit applications under the Dutch “WABO” process, with targeted first submission by Dec. 31, 2022. The submission includes filing of an environmental permit followed by construction permit application for phase 1 400,000 cubic meters (“CBM”) capacity. The latter will be a phased submission, with each phase designed in accordance with commercial storage requirements for the future planned expansion capacity for green and low-carbon energy products at the terminal. The company is on schedule to file the detailed environmental impact assessment known in the Netherlands as the “MER” (“Milieueffectrapport”) before Jan. 31, 2023, in compliance with the formal process and in close cooperation with the authorities.

To view the full press release, visit https://ibn.fm/7D9fK

About Vision Energy Corp.

Vision Energy is a forward-looking energy company developing assets and solutions for the commercial, industrial and transportation sectors. Vision Energy leverages its proven track record in site and asset procurement, accelerating development and permitting processes, plant design and grid integration to facilitate low-carbon energy production, supply and distribution. The company pursues reliable offtake relationships and operating partnerships with energy industry participants and end users seeking carbon abatements across feedstock and fuels. Vision Energy is committed to providing low carbon energy solutions with the highest yield, and where possible, projects are designed to leverage existing gas and power infrastructure to integrate and facilitate import and or distribution of reduced-carbon energy to domestic and global supply chains. For more information about the company, visit www.VisionEnergy.com.

NOTE TO INVESTORS: The latest news and updates relating to VENG are available in the company’s newsroom at https://ibn.fm/VENG

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html


EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF) Putting Organic Waste to Work, Not in Landfill, as Canada Strives for Emissions Goals

 

  • Alberta Research Council estimated Canada’s RNG production potential equivalent to 1,200 billion cubic feet annually, equal to ~1/3 of 2017 natural gas consumption
  • EverGen Infrastructure is leading the trend towards RNG, owning/operating 4 projects in western Canada with expansion into Ontario through 50% ownership in a large-scale project
  • Flush with cash, EverGen is expanding aggressively, with expectations for core projects to generate a range of $50-$60 million in annual revenue

Canada is stepping up its game in a bid to meet its goal of net zero emissions by 2050, a benchmark that has become the target of many countries worldwide. Currently, over 140 countries have officially set targets or are considering a net zero by 2050 commitment. In June 2021, Canada passed the Canadian Net-Zero Emissions Accountability Act, enshrining its vision into law, promptly following that in July by lowering its mid-term goal to emissions levels of 40-45% of 2005 levels by 2030, versus a prior mark of 30 percent. The regulatory atmosphere and social awareness situation couldn’t be better for companies like EverGen Infrastructure (TSX.V: EVGN) (OTCQX: EVGIF), which is aggressively expanding nationwide with its Renewable Natural Gas (“RNG”) infrastructure platform.

RNG is just like the name implies. Organic waste from sustainable sources such as farms, landfills, and sewage treatment plants are processed, creating a biogas refined into biomethane as output that is equivalent to conventional natural gas and ready for injection into existing pipelines. The digestate byproduct from the process provides solid and liquid end-products for use in other applications, such as fertilizer. The beauty of RNG is that it is produced from infinite sources, as humans and animals will forever produce waste. Decomposing waste contains large amounts of methane, carbon dioxide and hydrogen sulfide. Separating the methane from the contaminants and refining it to 95+ percent purity (just like traditional natural gas) spares the atmosphere from greenhouses gases being burned off or naturally emitted where they contribute to climate change.

It goes without mentioning that RNG creates clean gas without drilling a single hole in the ground, a criticism of natural gas production.

In the trend towards reuse and sustainability, RNG will play a substantial role. Natural gas is not only used in in homes and businesses, but also increasingly becoming popular in the transportation industry to cleanly power vehicles. In a 2013 report, the Alberta Research Council estimated Canada’s RNG production potential equivalent to 1,200 billion cubic feet annually. That’s more than one-third of the country’s natural gas consumption in 2017. On the continent level, North American gas utilities are targeting 5-15% renewables by volume compared to less than 1% today.

Amassing an impressive portfolio of projects and partners, EverGen is establishing itself as a name brand in the RNG industry. The British Columbia-based company acquires, develops, owns, and operates RNG projects using a platform approach to reliably build sustainable infrastructure to supply the North American gas grid with clean energy from organic waste. In the high-merging business, EverGen’s near-term pipeline has the potential to generate over $30 million in annual adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization).

EverGen began building its footprint with projects in its home province before moving east to where it now has operations in B.C., Alberta, and Ontario. The company currently has, owns and operates 4 RNG and/or organic processing facilities: Net Zero Waste Abbottsford (B.C), Fraser Valley Biogas (B.C), Sea to Sky Soils (B.C.), and 67% ownership in GrowTEC (Alberta). EverGen also has a 50% stake in Project Radius, a large, 3-phase RNG project in Ontario.

RNG produced at Net Zero Waste Abbottsford, Fraser Valley Biogas, and GrowTEC is bought by FortisBC via long-term (10-20 years) offtake agreements. In September, FortisBC agreed to purchase up to 190,000 gigajoules annually of RNG from Fraser Valley Biogas, meaning they’ll take what is produced currently, as well as securing future production as the project is currently being expanded.

At GrowTEC, RNG expansion is now 80 percent complete. To maintain its aggressive growth strategy, EverGen recently signed a term sheet for $31 million Senior Term Loan with its existing lender, a subsidiary of Scotiabank. Ultimately being a nice backstop to the $12.8 million in cash on hand at the end of the third quarter, inclusive of $3.5 million already earmarked for expansion projects.

By 2024, it is expected that the core group of projects can be producing 2 million gigajoules annually. At $25-$30 per gigajoule, that translates to $50-$60 million in revenue for EverGen.

For more information, visit the company’s website at www.EverGenInfra.com.

NOTE TO INVESTORS: The latest news and updates relating to EVGIF are available in the company’s newsroom at https://ibn.fm/EVGIF

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all

HeartBeam Inc. (NASDAQ: BEAT) CEO Featured Guest on Big Biz Show, Talks ‘Breakthrough’ Heart-Attack Detection Technology

 

  • BEAT has developed technology that collects data to synthesize a 12-lead 3D vector electrocardiogram (“VECG”)
  • The device provides physicians with a 12-lead ECG associated with chest pain compared to a baseline ECG for the patient
  • This key data enables physicians to assess whether symptoms may be the result of a heart attack

HeartBeam’s (NASDAQ: BEAT) small, portable, easy-to-use heart-attack detection solution was the focus of a recent Big Biz Show episode; the Big Biz Show features fast-talking, hard-hitting discussions on business and finance. During the interview, Big Biz Show host Bob “Sully” Sullivan chatted with HeartBeam founder and CEO Branislav Vajdic, PhD, about the company’s groundbreaking new device, the HeartBeam AIMIGo(TM) 12-lead 3D vector electrocardiogram recording device that is designed to detect heart attacks anytime, anywhere (https://ibn.fm/9rJre).

“Most people know how a 12-lead machine looks,” Vajdic said during the interview. “It’s on a cart with all these wires running around the body. We have developed a 3D-based vector card technology that enables this device to collect enough data to synthesize a 12-lead VECG and provide that to the physician. Every time a patient feels symptoms, they pull this device out of their wallet, press it against their chest, and declare how they feel on the app, and that goes to our cloud, where processing is happening.

Vajdic indicated that the device, which will be prescribed by healthcare providers, will enable physicians to assess whether symptoms may be the result of a heart attack. Contrary to the widely held view of a patient dropping to the floor with a heart attack, most heart attacks manifest themselves as chest pain, which can be of various intensities. Chest pain, explained Vajdic, can be a sign of an occluded artery.

“That means the heart is deprived of oxygen and the cardiac muscle is dying,” he said. “Yet not many people realize that. An average person waits over three hours before they act on chest pain.” After three hours, the “mortality rate goes up by about 40%, so many lives are lost because of that delay. The sooner you intervene, the more cardiac muscle you save.”

On the flip side, he noted, many people head to the ER at any sign of indigestion. About 82% of those visits end up being unnecessary, costing the system more than $10 billion. The lost lives and wasted dollars are what HeartBeam is hoping to eliminate with its HeartBeam AIMI(TM) technology.

The technology is unlike anything else currently available, stated Vajdic, who also called the device a “breakthrough” and noted that it offers personalized data. “Every heart is different,” he explained. “Our diagnostic engine uses your normal state to compare it to your chest pain or perhaps heart attack.”

Both these patented products —HeartBeam AIMI and HeartBeam AIMIGo — are in development. The company noted that it is also committed to continue advancing the full potential of cutting-edge, 12-lead 3D VECG technology. That commitment is demonstrated by recently issued and allowed patents that appear to have the potential for significant market impacts. HeartBeam AIMI and HeartBeam AIMIGo have not yet been cleared by the US Food and Drug Administration for marketing in the USA or other geographies.

For more information, visit the company’s website at www.HeartBeam.com.

NOTE TO INVESTORS: The latest news and updates relating to BEAT are available in the company’s newsroom at https://ibn.fm/BEAT

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all

Monday, December 19, 2022

MissionIRNewsBreaks – FingerMotion Inc.’s (NASDAQ: FNGR) JiuGe Technology, Munich Re Collaborate to Drive Commercial Application of Work

 FingerMotion (NASDAQ: FNGR), a mobile data and services company, today announced that its subsidiary, Shanghai JiuGe Information Technology Co. Ltd. (“JiuGe Technology”) and Munich Re, a large global reinsurer, have set the stage for extension of their ongoing behavioral research and analytic studies into commercial implementation in the China market. The partner companies, through a proprietary behavior intelligence system developed by “Sapientus,” the analytic innovation development arm of FingerMotion, will bring forward their jointly developed model algorithms and analytic insights for productionized applications and wider market adoption. “We are excited to walk together with Munich Re in driving commercial application of our work,” said Martin Shen, CEO of FingerMotion. “Today’s news reinforces a longer-term strategic mission to reinvent the way our partners provide insurance to customers in the future. We cannot stress more on addressing consumer demands for a more convenient insurance experience through analytic innovation. With this collaboration, we are well on our way towards realizing this common goal with our insurer partners in the near future.”

To view the full press release, visit https://ibn.fm/T0Xtv

About FingerMotion Inc.

FingerMotion is an evolving technology company with a core competency in mobile payment and recharge platform solutions in China. It is one of only a few companies in China with access to wholesale rechargeable minutes from China’s largest mobile phone providers that can be resold to consumers. As the user base of its primary business continues to grow, the company is developing additional value-added technologies to market to its users. The vision of the company is to rapidly grow the user base through organic means and have this growth develop into an ecosystem of users with high engagement rates utilizing its innovative applications. Developing a highly engaged ecosystem of users would strategically position the company to onboard larger customer bases. FingerMotion eventually hopes to serve over 1 billion users in the China market and eventually expand the model to other regional markets. For more information, visit the company’s website at www.FingerMotion.com.

NOTE TO INVESTORS: The latest news and updates relating to FNGR are available in the company’s newsroom at https://ibn.fm/FNGR

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html